Your browser doesn't support javascript.
loading
[Orbital Rosai-Dorfman disease: a case report].
Yue, Z F; Chen, L; Liu, S Y; Wei, R L.
Afiliación
  • Yue ZF; Department of Ophthalmology, the Second Affiliated Hospital of Navy Military Medical Hospital, Shanghai 200003, China.
  • Chen L; Department of Ophthalmology, the Second Affiliated Hospital of Navy Military Medical Hospital, Shanghai 200003, China.
  • Liu SY; Department of Ophthalmology, the Second Affiliated Hospital of Navy Military Medical Hospital, Shanghai 200003, China.
  • Wei RL; Department of Ophthalmology, the Second Affiliated Hospital of Navy Military Medical Hospital, Shanghai 200003, China.
Zhonghua Yan Ke Za Zhi ; 58(9): 706-708, 2022 Sep 11.
Article en Zh | MEDLINE | ID: mdl-36069092
ABSTRACT
A 19-year-old patient with bilateral eyelid swelling for more than 2 years visited the Department of Ophthalmology. Physical examination disclosed a moderately active mass in the upper eyelid and lacrimal gland area in each eye. Orbital MRI showed that the lacrimal glands were significantly enlarged and moved forward in both eyes, and the enlargement was more severe in the left eye. The patient was admitted twice to the hospital for removal of orbital masses and was diagnosed as orbital Rosai-Dorfman disease by histopathological examination. During three months of follow-up, the patient was in good physical condition, and there was no tumor recurrence.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Orbitales / Histiocitosis Sinusal / Aparato Lagrimal Tipo de estudio: Diagnostic_studies Límite: Adult / Humans Idioma: Zh Revista: Zhonghua Yan Ke Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Orbitales / Histiocitosis Sinusal / Aparato Lagrimal Tipo de estudio: Diagnostic_studies Límite: Adult / Humans Idioma: Zh Revista: Zhonghua Yan Ke Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China